Physician profile
Mohammad Taleb
NPI 1891928990
$3,600.99
in general payments reported to CMS, 2019-2025
32 companies · $1,285 in 2025
The $1,285 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $48.98 · 2021: $47.74 · 2023: $915 · 2024: $1,049 · 2025: $1,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,158 · Education: $90.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,158.37 |
| Education | $90.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $917.46 | 2023-2025 | Watchman Flx, Watchman Access System, Avvigo Guidance System |
| United Therapeutics Corporation | $274.17 | 2023-2025 | Tyvaso, Tyvaso |
| Astrazeneca Pharmaceuticals Lp | $261.21 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Merck Sharp & Dohme LLC | $188.07 | 2023-2025 | Recarbrio, Zerbaxa, Winrevair |
| Regeneron Healthcare Solutions, INC. | $176.41 | 2024-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $174.09 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Medtronic, INC. | $171.62 | 2024-2025 | Corevalve Evolut R, Onyx Frontier |
| Novartis Pharmaceuticals Corporation | $165.81 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $149.99 | 2019-2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $142.36 | 2023-2025 | Opsumit, Uptravi |
| Genzyme Corporation | $122.90 | 2024-2025 | |
| Glaxosmithkline, LLC. | $95.79 | 2023-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Novo Nordisk INC | $77.68 | 2019 | |
| Baxter Healthcare | $62.44 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Electromed, INC. | $60.51 | 2024-2025 | Smartvest |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $52.49 | 2019-2025 | Brinsupri, Arikayce |
| Ani Pharmaceuticals, INC. | $50.76 | 2024-2025 | Purified Cortrophin Gel |
| Grifols USA, LLC | $50.71 | 2025 | Prolastin-C Liquid |
| E.R. Squibb & Sons, L.L.C. | $50.54 | 2020-2024 | Camzyos |
| Intuitive Surgical, INC. | $47.74 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $42.58 | 2024 | |
| Pfizer INC. | $40.71 | 2023-2025 | |
| Kestra Medical Technology Services, INC. | $36.17 | 2023 | Assure Wcd |
| Inogen, INC. | $32.86 | 2023-2024 | Inogen |
| Viatris Specialty LLC | $25.29 | 2025 | Yupelri |
| Alexion Pharmaceuticals, INC. | $25.25 | 2025 | Ultomiris |
| Scpharmaceuticals INC. | $23.81 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.14 | 2023 | |
| Cardiva Medical, INC. | $20.77 | 2024 | Optowire |
| Cook Medical LLC | $15.63 | 2019 | |
| La Jolla Pharmaceutical Company | $13.11 | 2023 | Giapreza |
| Genentech USA, INC. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Taleb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.